Dr. Christina Bürger

Christina Bürger
Christina Bürger, with extensive experience in science management, has joined Hertie AI as the Managing Director. Having worked in various research and academic institutions, including the Institute of Medical Genetics and Applied Genomics, the Research Department at the University of Tübingen, and the Faculty of Medicine, Christina brings a wealth of knowledge. With a background in Biology and a Ph.D. from Ludwig-Maximilians University Munich, she has specialized expertise in research management and knowledge transfer. In her role, Christina oversees the institute's operations, collaborates with the board for strategic development, coordinates research programs, manages intramural funding projects, ensures quality assurance, and handles communication and international visibility efforts.
Working at Hertie AI allows me to contribute towards achieving our vision, fostering innovative research, collaboration, and international recognition in the dynamic field of artificial intelligence.
01
Lacy, M., Bürger, C., Shami, A. et al.

Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease.

Jun 18, 2021 | Nat Commun 12, 3754 (2021).
02
Shami, A., Atzler, D., Bosmans, L. A., Winkels, H., Meiler, S., Lacy, M.,...,Buerger, C., ... & Lutgens, E

Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans

Aug 14, 2020 | European heart journal, 41(31), 2938-2948.
03
Kusters, P., Seijkens, T., Bürger, C., Legein, B., Winkels, H., Gijbels, M., ... & Lutgens, E.

Constitutive CD40 signaling in dendritic cells limits atherosclerosis by provoking inflammatory bowel disease and ensuing cholesterol malabsorption.

Dec 17, 2017 | The American Journal of Pathology, 187(12), 2912-2919.